SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-003731
Filing Date
2017-05-08
Accepted
2017-05-08 09:31:09
Documents
51
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20170331x10q.htm 10-Q 945282
2 EX-31.1 glyc-20170331ex311cdc35d.htm EX-31.1 18268
3 EX-31.2 glyc-20170331ex312495a14.htm EX-31.2 17319
4 EX-32.1 glyc-20170331ex3218b2d76.htm EX-32.1 10304
  Complete submission text file 0001558370-17-003731.txt   3979668

Data Files

Seq Description Document Type Size
5 EX-101.INS glyc-20170331.xml EX-101.INS 808890
6 EX-101.SCH glyc-20170331.xsd EX-101.SCH 27292
7 EX-101.CAL glyc-20170331_cal.xml EX-101.CAL 28068
8 EX-101.DEF glyc-20170331_def.xml EX-101.DEF 127283
9 EX-101.LAB glyc-20170331_lab.xml EX-101.LAB 270563
10 EX-101.PRE glyc-20170331_pre.xml EX-101.PRE 227057
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 17820826
SIC: 2834 Pharmaceutical Preparations